Postmyocardial Infarction

• FDA approval · 2025-06-05
  FDA Approved: VALSARTAN — Original Application (Advagen Pharma Ltd)

  FDA approved the original application for a generic valsartan oral tablet from Advagen Pharma Ltd.

• FDA approval · 2022-08-17
  FDA Approved: VALSARTAN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)

  The FDA approved a supplemental application for valsartan from Jubilant Cadista Pharmaceuticals Inc. This approval indicates regulatory auth…

• FDA label_change · 2015-07-27
  FDA Approved: DIOVAN — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for DIOVAN (valsartan) submitted by Novartis Pharmaceuticals Corporation, resulting in changes to th…

• FDA approval · 2014-09-26
  FDA Approved: RAMIPRIL — Supplemental Application (Zydus Lifesciences Limited)

  FDA approved a supplemental application for RAMIPRIL (ramipril) from Zydus Lifesciences Limited.

• FDA approval · 2014-09-21
  FDA Approved: CARVEDILOL — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for carvedilol from Aurobindo Pharma Limited, confirming a generic version under ANDA078332.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.